Medacta Group SA/Fr. MOVE
08:00
10:05
12:10
14:15
16:20
1D1W1MYTD1Y5YMAX
About Medacta Group SA
Medacta Group SA is a Swiss-based company specializing in the design, production, and distribution of orthopedic medical devices. The company's core business focuses on hip and knee replacement products, as well as spine surgery and sports medicine solutions. Founded in 1999, Medacta is headquartered in Castel San Pietro, Switzerland. The company distinguishes itself through its commitment to medical education, providing training and resources to healthcare professionals to enhance surgical outcomes. Medacta also emphasizes innovation in minimally invasive surgical techniques and personalized solutions to improve patient care and recovery times.
Ticker
Fr. MOVE
Sector
Primary listing
XSWX
Employees
2,041
Headquarters
Castel San Pietro, Switzerland
Website
Medacta Group SA Metrics
BasicAdvanced
CHF 3.1B
36.42
CHF 4.30
1.08
CHF 0.69
0.22%
Price and volume
Market cap
CHF 3.1B
Beta
1.08
52-week high
CHF 177.20
52-week low
CHF 104.60
Average daily volume
17K
Dividend rate
CHF 0.69
Financial strength
Current ratio
2.394
Quick ratio
0.816
Long term debt to equity
41.615
Total debt to equity
60.015
Dividend payout ratio (TTM)
15.44%
Interest coverage (TTM)
7.42%
Profitability
EBITDA (TTM)
146.059
Gross margin (TTM)
67.61%
Net profit margin (TTM)
14.69%
Operating margin (TTM)
16.72%
Effective tax rate (TTM)
15.02%
Revenue per employee (TTM)
CHF 289,100
Management effectiveness
Return on assets (TTM)
8.48%
Return on equity (TTM)
24.70%
Valuation
Price to earnings (TTM)
36.417
Price to revenue (TTM)
5.343
Price to book
7.32
Price to tangible book (TTM)
8.4
Price to free cash flow (TTM)
133.316
Free cash flow yield (TTM)
0.75%
Free cash flow per share (TTM)
1.175
Dividend yield (TTM)
0.44%
Forward dividend yield
0.22%
Growth
Revenue change (TTM)
18.70%
Earnings per share change (TTM)
69.46%
3-year revenue growth (CAGR)
17.63%
3-year earnings per share growth (CAGR)
26.17%
3-year dividend per share growth (CAGR)
12.54%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Medacta Group SA stock?
Medacta Group SA (MOVE) has a market cap of Fr.3.1B as of March 15, 2026.
What is the P/E ratio for Medacta Group SA stock?
The price to earnings (P/E) ratio for Medacta Group SA (MOVE) stock is 36.42 as of March 15, 2026.
Does Medacta Group SA stock pay dividends?
Yes, the Medacta Group SA (MOVE) stock pays dividends to shareholders. As of March 15, 2026, the dividend rate is Fr.0.69 and the yield is 0.22%. Medacta Group SA has a payout ratio of 15.44% on a trailing twelve-month basis.
When is the next Medacta Group SA dividend payment date?
The next Medacta Group SA (MOVE) dividend payment is scheduled for May 11, 2026.
What is the beta indicator for Medacta Group SA?
Medacta Group SA (MOVE) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.